
Ketorolac vs. Depomedrol Injections for Subacromial Impingement
How to Cite
OrthoEvidence. Ketorolac vs. Depomedrol Injections for Subacromial Impingement. ACE Report. 2022;228(1):1. Available from: https://myorthoevidence.com/AceReport/Report/14520
Outcomes of ketorolac versus depomedrol infiltrations for subacromial impingement syndrome: a randomized controlled trial
Musculoskelet Surg . 2022 Mar;106(1):29-34.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seventy patients with subacromial impingement syndrome were randomized to receive a subacromial depomedrol injection (n=35) or a subacromial ketorolac injection (n=35). The outcomes of interest included pain, function and range of motion at one and three month follow-up. There was no significant differences in pain as measured by a visual analogue scale. No differences in function between the two ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!


Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE
Please Login or Join to leave comments.